ISHARES TR's ticker is IBB and the CUSIP is 464287556. A total of 898 filers reported holding ISHARES TR in Q1 2022. The put-call ratio across all filers is 0.80 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $363,669 | +3.1% | 2,649 | +3.0% | 0.05% | +2.1% |
Q1 2024 | $352,860 | +3.1% | 2,571 | +2.1% | 0.05% | -5.9% |
Q4 2023 | $342,129 | +8.5% | 2,518 | -2.3% | 0.05% | -1.9% |
Q3 2023 | $315,300 | -4.2% | 2,578 | -0.6% | 0.05% | 0.0% |
Q2 2023 | $329,245 | -1.1% | 2,593 | +0.7% | 0.05% | -7.1% |
Q1 2023 | $332,754 | -3.7% | 2,576 | -2.1% | 0.06% | -9.7% |
Q4 2022 | $345,524 | +5.3% | 2,632 | -6.1% | 0.06% | -3.1% |
Q3 2022 | $328,000 | +32.3% | 2,803 | +32.8% | 0.06% | +36.2% |
Q2 2022 | $248,000 | +5.1% | 2,111 | +16.6% | 0.05% | +20.5% |
Q1 2022 | $236,000 | -22.1% | 1,810 | -8.9% | 0.04% | -15.2% |
Q4 2021 | $303,000 | +15.2% | 1,986 | +21.9% | 0.05% | +2.2% |
Q3 2021 | $263,000 | +27.1% | 1,629 | +19.1% | 0.04% | +7.1% |
Q4 2020 | $207,000 | +223.4% | 1,368 | +160.6% | 0.04% | +281.8% |
Q3 2018 | $64,000 | +23.1% | 525 | +11.5% | 0.01% | +22.2% |
Q2 2018 | $52,000 | -5.5% | 471 | -8.4% | 0.01% | -10.0% |
Q1 2018 | $55,000 | – | 514 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Atom Investors LP | 78,501 | $10,139,189 | 5.52% |
Bronte Capital Management Pty Ltd. | 302,076 | $39,016,136 | 4.53% |
Michelson Medical Research Foundation, Inc. | 43,395 | $5,604,898 | 4.40% |
Hackensack Meridian Health, Inc. | 228,000 | $29,448,480 | 4.26% |
DAFNA Capital Management LLC | 102,500 | $13,238,900 | 3.97% |
Richmond Brothers, Inc. | 16,724 | $2,159,856 | 3.64% |
Alpha Family Trust | 34,549 | $4,462,349 | 3.53% |
HANSEATIC MANAGEMENT SERVICES INC | 11,897 | $1,537 | 3.46% |
PURSUE WEALTH PARTNERS LLC | 37,789 | $4,880,827 | 3.33% |
Rye Brook Capital LLC | 40,100 | $5,179 | 3.17% |